ロード中...
Lenalidomide-Associated Immune Thrombocytopenia: A Case Report and Review of the Literature
Lenalidomide is indicated in the front-line management of multiple myeloma. More recently, it has been introduced for use in treating other hematologic malignancies. Although the drug is known to cause myelosuppression, there have been rare reports of lenalidomide-associated immune thrombocytopenia...
保存先:
| 出版年: | Case Rep Hematol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7676979/ https://ncbi.nlm.nih.gov/pubmed/33274089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8825618 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|